Augustine Therapeutics
augustinetx.com
Actively hiring
Biotechnology
Cardiometabolic Therapeutics
Neurology & CNS Therapeutics
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
3
Asabys Partners, Jeito Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Asabys Partners 
Jeito Capital 
V-Bio Ventures Similar startupsby what they do, their industry and backers
Brenig Therapeutics develops innovative small-molecule therapies for neurodegenerative diseases, including LRRK2 inhibitors targeting…
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
Draupnir Bio is developing new innovative therapies for patients.
We are on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases.
We’re building a pipeline of next-generation therapeutics focused on broadening the treatment paradigm for migraine and other headache…